http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, according to research published in the Oct. 1 issue of Clinical Cancer Research. http://medicalxpress.com/news/2012-11-optimal-dose-dasatinib-ovarian-cancer.html Cancer Mon, 19 Nov 2012 10:00:13 EST news272540632 Researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the United States and the United Kingdom have used two genome-wide association studies (GWAS) – one from the U.S. and one from the U.K. – to detect a novel set of genes found to be associated with epithelial ovarian cancer patient survival. The discovery could open the door to new therapies for treating epithelial ovarian cancer (EOC), the most lethal kind of gynecologic malignancy. http://medicalxpress.com/news/2012-03-genetic-keys-surviving-epithelial-ovarian.html Cancer Tue, 06 Mar 2012 11:17:52 EST news250255050